A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.

NCT00232856 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

162

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: drug-eluting stent

Sponsor

Cordis US Corp.